IntrinsicIntrinsic
← Scroll for more →

Financial Statements — NRDE

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents0.020.030.030.020.030.030.020.030.020.020.090.090.120.110.120.150.240.200.240.23
Short-term Investments0.010.010.000.01--0.010.01----------0.020.070.100.05--------
Accounts Receivable----------------------------------------
Inventory--------------------------0.010.010.010.00------
Total Current Assets0.030.040.040.050.050.050.050.060.060.080.090.100.150.190.260.250.280.240.290.26
Property, Plant & Equipment--------------------------0.080.190.220.290.410.380.36
Total Non-current Assets*0.010.010.000.000.000.000.000.000.000.000.000.010.010.080.200.250.320.420.400.37
Total Assets0.040.040.050.050.050.050.050.060.060.080.090.110.160.270.450.500.600.660.690.62
Accounts Payable0.000.000.000.000.000.000.000.000.000.000.000.000.000.010.010.020.010.010.010.05
Short-term Debt------------------------------0.010.01------
Total Current Liabilities0.000.000.000.000.000.000.000.000.000.010.020.020.020.060.070.090.060.200.150.09
Total Non-current Liabilities*0.000.000.010.010.010.010.010.010.020.030.030.040.090.000.000.000.000.000.000.00
Total Liabilities0.000.000.010.010.010.010.010.020.020.040.050.060.100.060.070.090.060.210.150.09
Retained Earnings(1.18)(1.18)(1.18)(1.18)(1.18)(1.18)(1.18)(1.18)(1.18)(1.18)(1.17)(1.17)(1.15)(1.00)(0.83)(0.73)(0.57)(0.63)(0.54)(0.46)
Total Stockholder Equity0.000.000.000.000.000.000.010.010.010.010.010.010.030.180.350.410.540.450.540.53
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue--------------0.000.00--0.000.002.150.19------------
Cost of Revenue--------------0.000.00--0.000.0060.7430.81------------
Gross Profit--------------0.00(58.59)--0.000.00(89.21)(30.62)------------
Research & Development--------------------0.905.7212.3014.4315.6019.8410.5161.8658.7756.89
Selling, General & Admin1.551.501.921.231.681.943.87--------------------------
Total Operating Expenses1.550.722.05(0.42)0.361.771.420.52(0.53)9.483.6117.5095.03143.55176.03154.85(61.28)87.8884.6699.28
Operating Income(1.55)(0.72)(2.05)0.42(0.36)(1.77)(1.42)(0.52)0.53(9.48)(3.61)(17.49)(153.62)(174.17)(205.86)(154.85)61.29(87.88)(84.66)(99.28)
Pretax Income(1.06)(0.11)(1.10)0.960.74(1.21)(1.48)0.341.48(8.47)(0.35)(16.51)(154.49)(171.72)(102.00)(154.43)63.66(89.63)(81.15)(95.81)
Net Income(1.06)(0.11)(1.10)0.960.74(1.21)(1.48)0.341.48(8.47)(0.35)(16.51)(154.49)(171.72)(102.00)(154.43)63.66(89.63)(81.15)(95.81)
Basic EPS(0.11)(0.05)(0.12)0.01(0.12)(0.12)(0.13)(0.02)0.05(0.57)(10.24)(1.03)(9.69)(0.71)(0.48)(0.73)0.32(0.46)(0.40)--
Diluted EPS(0.11)(0.05)(0.12)0.01(0.12)(0.12)(0.13)(0.02)0.05(0.57)(10.24)(1.03)(9.69)(0.71)9.69--0.32(0.43)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(0.94)(2.60)(1.58)(1.67)(2.14)(1.84)(5.11)(5.23)(15.18)(9.55)(17.16)(44.31)(37.58)(38.12)(42.74)(49.59)(52.39)(69.03)(141.75)(74.87)
Capital Expenditures--------------------0.00(0.04)2.247.954.0010.5218.1521.9028.9979.93
Free Cash Flow*--------------------(17.16)(44.28)(39.82)(46.06)(46.75)(60.11)(70.54)(90.93)(170.74)(154.79)
Investing Cash Flow(2.66)(6.72)17.79(9.63)0.4110.00--------10.6022.2445.2224.84(40.35)(58.56)5.91(21.90)(29.99)(79.93)
Financing Cash Flow------------0.000.000.00(0.11)--------50.2226.7178.6150.48181.9222.72
← Scroll for more columns →

* Derived from reported values